(Q34436579)

English

Vasopeptidase inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

Vasopeptidase inhibitors. (English)

1 reference

Europe PubMed Central

2 August 2017

author name string

M A Weber

1

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

358

1 reference

Europe PubMed Central

2 August 2017

9292

1 reference

Europe PubMed Central

2 August 2017

1525-1532

1 reference

Europe PubMed Central

2 August 2017

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevention of heart failure--a new agenda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Natriuretic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Physiological role of silent receptors of atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of neutral endopeptidase in the metabolism of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasopeptidase inhibitors: incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of omapatrilat in low, normal, and high renin experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Disposition and safety of omapatrilat in subjects with renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of omapatrilat on systemic arterial function in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906584-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(01)06584-9

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34436579&oldid=2037277001"